Literature DB >> 29408585

The Upper Esophageal Sphincter Assist Device Is Associated With Symptom Response in Reflux-Associated Laryngeal Symptoms.

Rena Yadlapati1, Jenna Craft2, Christopher J Adkins3, John E Pandolfino2.   

Abstract

Reflux-associated laryngeal symptoms (RALS) is the process in which chronic laryngeal symptoms are related to gastroesophagopharyngeal reflux.1 Impairment of upper esophageal sphincter (UES) reflexes may predispose to esophagopharyngeal reflux.1 The novel noninvasive nonpharmacologic UES assist device (UESAD) applies external cricoid pressure to augment intraluminal UES pressure by 20 to 30 mm Hg and reduce esophagopharyngeal reflux events.2 This study aimed to assess the therapeutic efficacy of the UESAD in a pragmatic clinical setting, and to identify factors associated with symptom response among patients with suspected RALS.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2018        PMID： 29408585      PMCID： PMC6067982          DOI： 10.1016/j.cgh.2018.01.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  6 in total

1.  Impaired upper esophageal sphincter reflexes in patients with supraesophageal reflux disease.

Authors:  Arash Babaei; Mukund Venu; Sohrab Rahimi Naini; Jason Gonzaga; Ivan M Lang; Benson T Massey; Sudarshan Jadcherla; Reza Shaker
Journal:  Gastroenterology       Date:  2015-07-17       Impact factor: 22.682

2.  The development and validation of a Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults.

Authors:  B M Spiegel; L Roberts; R Mody; G Harding; S Kothari-Talwar; P J Kahrilas; M L Camilleri; O Dabbous; D A Revicki
Journal:  Aliment Pharmacol Ther       Date:  2010-06-02       Impact factor: 8.171

3.  Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier.

Authors:  Reza Shaker; Arash Babaei; Sohrab R Naini
Journal:  Laryngoscope       Date:  2014-06-27       Impact factor: 3.325

4.  Abilities of Oropharyngeal pH Tests and Salivary Pepsin Analysis to Discriminate Between Asymptomatic Volunteers and Subjects With Symptoms of Laryngeal Irritation.

Authors:  Rena Yadlapati; Christopher Adkins; Diana-Marie Jaiyeola; Alcina K Lidder; Andrew J Gawron; Bruce K Tan; Nadine Shabeeb; Caroline P E Price; Neelima Agrawal; Michael Ellenbogen; Stephanie S Smith; Michiel Bove; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2015-12-09       Impact factor: 11.382

5.  Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.

Authors:  R Jones; O Junghard; J Dent; N Vakil; K Halling; B Wernersson; T Lind
Journal:  Aliment Pharmacol Ther       Date:  2009-09-08       Impact factor: 8.171

6.  Validity and reliability of the reflux symptom index (RSI).

Authors:  Peter C Belafsky; Gregory N Postma; James A Koufman
Journal:  J Voice       Date:  2002-06       Impact factor: 2.009
  6 in total
  2 in total

Review 1.  An update on current treatment strategies for laryngopharyngeal reflux symptoms.

Authors:  Amanda J Krause; Erin H Walsh; Philip A Weissbrod; Tiffany H Taft; Rena Yadlapati
Journal:  Ann N Y Acad Sci       Date:  2021-12-17       Impact factor: 6.499

2.  The Upper Esophageal Sphincter Distensibility Index Measured Using Functional Lumen Imaging Probe Identifies Defective Barrier Function of the Upper Esophageal Sphincter.

Authors:  Lucie F Calderon; Meredith Kline; Marc Hersh; Kevin P Shah; Suprateek Kundu; Andrew Tkaczuk; Nancy McColloch; AnS Jain
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.